Atrás
Rango del Día
$15.36
$16.13
Rango de 52 Semanas
$13.83
$36.91
Volumen
2,029,714
Promedio 50D / 200D
$15.90
/
$19.97
Cierre Anterior
$15.60
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -10.7 | 0.3 |
| P/B | 17.6 | 2.9 |
| ROE % | -206.1 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$26.00
+67.3%
Low: $16.00
High: $40.00
EPS Futuro
-$1.15
Ingresos Est.
8.6 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.89
$0.13 – $4.60
|
4.4 B | 2 |
| FY2029 |
$0.65
$0.05 – $1.58
|
2.5 B | 4 |
| FY2028 |
-$0.02
-$0.15 – $0.20
|
940 M | 6 |
Puntos Clave
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -323.59M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-206.10%
ROIC-90.33%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.02
Current Ratio9.87
Interest Coverage0.00
Valoración
P/E Ratio
-10.72
P/B Ratio17.56
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -1.08B |
| ROE | -206.10% | ROA | -143.72% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -323.59M |
| ROIC | -90.33% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 9.87 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -10.72 | P/B Ratio | 17.56 |
| P/S Ratio | N/A | PEG Ratio | -0.03 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 11.57B | Enterprise Value | 11.36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 704,295.0 | 1.81M |
| Net Income | -1.08B | -221.32M | -614.93M | -78.78M | -88.60M |
| EPS (Diluted) | -1.44 | -0.31 | -0.99 | -0.38 | -0.96 |
| Gross Profit | -108,355.0 | -15.01M | -2.05M | -1.81M | 1.81M |
| Operating Income | -812.24M | 313,000.0 | -89.74M | -59.63M | -86.19M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 751.18M | 435.56M | 202.95M | 664.17M | 113.37M |
| Total Liabilities | 92.32M | 46.81M | 125.26M | 537.51M | 30.09M |
| Shareholders' Equity | 658.86M | 388.75M | 77.69M | 126.65M | 83.28M |
| Total Debt | 15.50M | 7.22M | 106.10M | 518.76M | 2.78M |
| Cash & Equivalents | 225.27M | 104.86M | 71.43M | 348.61M | 71.79M |
| Current Assets | 720.30M | 423.75M | 189.71M | 656.71M | 97.31M |
| Current Liabilities | 72.99M | 41.73M | 20.41M | 38.78M | 25.62M |